title: Smokeless tobacco potentiates VIP-induced DNA synthesis and inactivates NEP 24.11 in oral keratinocytes.
abstract: The purpose of this study was to determine whether exposure of cultured chemically transformed hamster oral keratinocytes (HCPC-1) to an aqueous extract of smokeless tobacco (STE) potentiates DNA synthesis elicited by vasoactive intestinal peptide (VIP), an autocrine neuropeptide, and, if so, whether this response is associated with inactivation of neutral endopeptidase 24.11 (NEP 24. 11), an ectoenzyme that cleaves and inactivates VIP very effectively, in these cells. I found that STE and VIP each elicited a modest, albeit significant, increase in DNA synthesis in cultured HCPC-1 cells (P < 0.05). However, incubation of HCPC-1 cells with STE together with VIP evoked a significant, concentration- dependent increase in DNA synthesis that was mediated by VIP receptors. The effects of STE and VIP were synergistic. Maximal response was observed after a 48-h incubation. STE significantly attenuated NEP 24.11 activity in HCPC-1 cells at a time when VIP-induced DNA synthesis was maximal. Collectively, these data indicate that STE potentiates VIP-induced DNA synthesis in cultured oral keratinocytes, and that this response is temporally related to STE-induced inactivation of NEP 24.11 in these cells. I suggest that NEP 24.11 modulates the mitogenic effects of smokeless tobacco in the oral epithelium, in part, by inactivating VIP.
authors.affiliation: Department of Medicine, University of Illinois at Chicago; and West Side Department of Veterans Affairs Medical Center, Chicago, Illinois 60612, USA. IRubinst@uic.edu
authors.forename: I
authors.initials: I
authors.lastname: Rubinstein
mesh_terms: D000818:Animals; D000963:Antimetabolites / Q000378:metabolism / Q000494:pharmacology; D001973:Bromodeoxyuridine / Q000378:metabolism / Q000494:pharmacology; D002461:Cell Line, Transformed; D006224:Cricetinae; D004247:DNA / Q000096:biosynthesis; D004789:Enzyme Activation / Q000187:drug effects; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D007971:Leukoplakia / Q000139:chemically induced; D008647:Mesocricetus; D009061:Mouth Mucosa / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D009062:Mouth Neoplasms / Q000139:chemically induced / Q000378:metabolism; D015260:Neprilysin / Q000378:metabolism*; D010947:Plants, Toxic; D014030:Tobacco, Smokeless / Q000009:adverse effects*; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
chemical_list: D000963:Antimetabolites; D014660:Vasoactive Intestinal Peptide; D004247:DNA; D015260:Neprilysin; D001973:Bromodeoxyuridine